Savaş Yeşilçay told Newsweek: "I tried to stay strong because I was far from family, fighting alone with only my cat Shiva by my side." ...

MSD has started a phase 3 trial of ROR1-directed zilovertamab vedotin (zilo-V) as a treatment for previously untreated diffuse large B-cell lymphoma (DLBCL), cementing the antibody-drug conjugate ...